Business Context and Reporting Period
This Form 8-K filing by CenterPoint Energy, Inc. covers the event date of December 31, 2011. The report addresses a material modification to the rights of security holders regarding the company's poison pill defense mechanism.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of a corporate governance event and contains no financial performance data.
Material Changes
On December 31, 2011, the Rights Agreement between CenterPoint Energy, Inc. and JPMorgan Chase Bank, dated January 1, 2002, expired by its terms. Consequently, shares of the Company's common stock are no longer accompanied by a right to purchase Series A Preferred Stock under certain circumstances. No shares of Series A Preferred Stock were outstanding or had been issued at the time of expiration.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the expiration of the Rights Agreement.
Investor Verification Checklist
- Confirm the expiration date of the Rights Agreement (December 31, 2011).
- Verify that no Series A Preferred Stock was outstanding or issued.
- Check subsequent filings for the adoption of any new shareholder rights plans.